|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.27 USD | -2.70% |
|
-1.35% | -19.43% |
| 07:15am | News Highlights : Top Company News of the Day - Friday at 1 AM ET | DJ |
| 05:15am | News Highlights : Top Company News of the Day - Thursday at 11 PM ET | DJ |
Aug 10 (Reuters) - Gilead Sciences Inc said on Monday it has filed a marketing application with the U.S. Food and Drug Administration for its experimental COVID-19 drug remdesivir. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)
| 1st Jan change | Capi. | |
|---|---|---|
| -19.43% | 81.39B | |
| +25.68% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.17% | 233B | |
| +5.40% | 201B | |
| -9.86% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
GILEAD SCIENCES, INC. 
